Last reviewed · How we verify
Allogenix Plus
Allogenix Plus is an allogeneic cellular therapy that uses donated human cells to promote tissue regeneration and repair.
Allogenix Plus is an allogeneic cellular therapy that uses donated human cells to promote tissue regeneration and repair. Used for Tissue repair and regeneration (specific indication not publicly detailed).
At a glance
| Generic name | Allogenix Plus |
|---|---|
| Sponsor | University of Missouri-Columbia |
| Drug class | Allogeneic cell therapy |
| Modality | Biologic |
| Therapeutic area | Regenerative Medicine |
| Phase | FDA-approved |
Mechanism of action
This product is derived from allogeneic (donor) cells that are processed and formulated to support healing and regeneration in damaged or diseased tissues. The mechanism likely involves delivery of viable or processed cells that can differentiate, secrete bioactive factors, or modulate the immune environment to facilitate tissue repair and restoration of function.
Approved indications
- Tissue repair and regeneration (specific indication not publicly detailed)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |